By Business/Source
Currency:CNY
2026/H1
Stock NameRevenueRatio
销售眼科药物15.37M81.63%
Sale of other drugs1.54M8.15%
独家分销权收入998K5.30%
销售眼科产品725K3.85%
CMO服务收入201K1.07%
By Product
Currency:CNY
2026/H1
Stock NameRevenueRatio
销售眼科药物15.37M81.63%
Sale of other drugs1.54M8.15%
独家分销权收入998K5.30%
销售眼科产品725K3.85%
CMO服务收入201K1.07%
By Country/Region
Currency:CNY
2026/H1
Stock NameRevenueRatio
China Mainland17.21M91.41%
South Korea745K3.96%
Other454K2.41%
中国香港(所在地)418K2.22%
